Two-Thirds of 340B DSH Hospitals Are Not Located in Medically Underserved Areas
Analysis Raises Questions on How 340B DSH Hospitals Are Providing Care to Underserved Communities if They Are Not Located in […]
340B In The News
IQVIA: The 340B Drug Pricing Program Exceeds $100B in 2022
This article is the latest in IQVIA’s series of yearly reports on the size and growth of the 340B drug
The New York Times: How a Hospital Chain Used a Poor Neighborhood to Turn Huge Profits
Bon Secours Mercy Health, a major nonprofit health system, used the poverty of Richmond Community Hospital’s patients to tap into
The Wall Street Journal: Many Hospitals Get Big Drug Discounts. That Doesn’t Mean Markdowns for Patients.
A decades-old federal program that offered big drug discounts to a small number of hospitals to help low-income patients now
30 Years of 340B: Policymakers Must Act Now to Prioritize Transparency, Accountability, and Oversight
With the 340B program marking its 30th anniversary in November, we must ask: who is benefiting from this drug pricing
AIR340B to FTC: Outsized role of PBMs in safety-net program harms vulnerable patients
For vulnerable patients across America, getting the 340B Drug Pricing Program right could be the difference between receiving lifesaving care
340B hospital charity care levels still abysmal despite growth in safety-net program
With the unparalleled effects of the COVID-19 pandemic, it makes sense that health care is a top concern for Americans.
Washington Needs to Put the Federal 340B Drug Discount Program Under the Microscope
Complex health care regulation is always a work in progress. Consider the Affordable Care Act (ACA), which has helped millions
This safety-net program is failing many vulnerable patients
Many poor Americans, as well as those who lack good insurance, often struggle with the high costs of health care
2021 AIR340B Summit
On Wednesday, May 26, the Alliance for Integrity and Reform of 340B hosted its annual Stakeholder Summit to discuss the